Risk factors for haemorrhage in patients with haematological malignancies
<p>Haematological malignancies and their treatment lead to prolonged periods of severe thrombocytopenia (platelet count ≤ 50 x 10<sup>9</sup>/l). Despite the use of prophylactic platelet transfusions, haemorrhage remains an important complication during this thrombocytopenic period...
मुख्य लेखक: | |
---|---|
अन्य लेखक: | |
स्वरूप: | थीसिस |
भाषा: | English |
प्रकाशित: |
2014
|
विषय: |